Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | COPD Clinical Trials in Houston | 162 Studies

Clinical Trials COPDHouston

COPD Clinical Trials in Houston

Find 162 clinical trials for copd near Houston, Texas. Connect with research centers in your area.

All COPD trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 162 trials

CompletedLong Term Safety Study of NVA237 vs QAB149 in COPD PatientsThe purpose of the study is to provide long term safety data of NVA237. This study will assess the safety and tolerability of a single dose strength of NVA237.NCT01697696·Gulf Shores, Alabama and 60 others

PreviousPage 8 of 9Next

COPD Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingVideo Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients…NCT05119556·Birmingham, Alabama and 14 others

RecruitingmyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeParallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care…NCT05204888·Birmingham, Alabama and 26 others

CompletedEffect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)The aim of the study is to compare the effect of roflumilast on exacerbation rate and pulmonary function in patients with chronic obstructive pulmonary disease (COPD).NCT00297115·Bayou La Batre, Alabama and 286 others

CompletedEfficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsThe purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab administered subcutaneously (SC) in adult participants with symptomatic COPD with a…NCT06040086·Birmingham, Alabama and 367 others

CompletedSurvival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.NCT00268216·Birmingham, Alabama and 458 others

CompletedStudy to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Primary Objective: Primary population (former smokers cohort): * Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe…NCT04751487·Phoenix, Arizona and 296 others

Enrolling by invitationGlobal Utilization And Registry Database for Improved preservAtion of doNor LUNGsThe objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported…NCT04930289·Phoenix, Arizona and 14 others

CompletedSafety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary DiseaseThis study is being conducted to see if PRX-08066 can lower pulmonary artery pressures in patients with pulmonary hypertension associated with chronic obstructive pulmonary…NCT00345774·Anniston, Alabama and 18 others

CompletedSafety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThis study assessed the safety/tolerability of 28 days of treatment with NVA237 100 µg and 200 µg once a day, compared to placebo in patients with moderate or severe Chronic…NCT00510510·Glendale, Arizona and 20 others

CompletedEvaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator MonotherapyA multicenter study to evaluate lung function and symptoms in subjects with COPD who have been on regular use of only one long-acting bronchodilator.NCT00791518·Birmingham, Alabama and 56 others

CompletedA Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.To assess the effects and safety of PF-00610355 on patients with chronic obstructive lung disease (COPD)NCT00808288·Fairhope, Alabama and 74 others

Active not recruitingA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have…NCT05878769·Birmingham, Alabama and 480 others

CompletedPivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationPrimary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary Disease (COPD) as measured…NCT04456673·Cullman, Alabama and 333 others

CompletedEfficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)The purpose of this Phase III study is to evaluate the long-term safety and tolerability of two fixed-dose combinations of inhaled aclidinium bromide/formoterol fumarate…NCT01572792·Anniston, Alabama and 207 others

CompletedA Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPDThe purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.NCT00280371·Jasper, Alabama and 51 others

CompletedMulti-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)This is a multicenter, randomized, double-blind, parallel group, chronic-dosing (24 weeks), placebo-controlled study to assess the efficacy and safety of Glycopyrrolate (GP and…NCT01854658·Birmingham, Alabama and 112 others

CompletedObservational Study of Obstructive Lung Disease (NOVELTY)The NOVEL Observational longiTudinal studY (NOVELTY) is an observational study of obstructive lung disease and is a multi-country, multi-centre, prospective, longitudinal cohort…NCT02760329·Loma Linda, California and 330 others

CompletedCombivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary DiseaseThe primary objective of this study is to evaluate long-term safety and patient acceptability of COMBIVENT RESPIMAT Inhalation Spray as compared to the COMBIVENT Inhalation…NCT01019694·Jasper, Alabama and 54 others

CompletedTiotropium / Respimat One-Year StudyTo evaluate the long term effects of treatment with two doses of Tiotropium delivered by the Respimat inhaler in patients with COPD.NCT00168831·Birmingham, Alabama and 75 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia